Improved network performance via antagonism: From synthetic rescues to multi-drug combinations

BioEssays

Volumn 32, Issue 3, 2010, Pages 236-245

  Motter, Adilson E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Antagonistic interactions; Biological networks; Cascade control; Cellular metabolism

Indexed keywords

CIPROFLOXACIN; DOXORUBICIN; DOXYCYCLINE; IMATINIB; PACLITAXEL; SPIRAMYCIN; SUNITINIB; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ARTICLE; CELL METABOLISM; DRUG ANTAGONISM; DRUG POTENTIATION; GENE INTERACTION; HUMAN; HUMAN CELL; METABOLIC DISORDER; NONHUMAN;

ANIMALS; COMPUTER SIMULATION; DRUG ANTAGONISM; DRUG THERAPY, COMBINATION; GENE KNOCKOUT TECHNIQUES; GENE REGULATORY NETWORKS; GENE THERAPY; HUMANS; METABOLIC DISEASES; METABOLIC NETWORKS AND PATHWAYS; NEOPLASMS;

EID: 77649133418     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.200900128     Document Type: Article

References (60)

1. Miller G. 1992. Lorenzo's Oil. USA: Universal Pictures.
2. Suddaby D, Coupland K. 1994. Pharmaceutical compositions for treating adrenoleukodystrophy. US Patent 5331009. USA: Croda International plc.
3. Kitano H. 2002. Systems biology: a brief overview. Science 295: 1662-4.
4. Duarte NC, Becker SA, Jamshidi N, et al. 2007. Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc Natl Acad Sci USA 104: 1777-82.
5. Motter AE, Gulbahce N, Almaas E, et al. 2008. Predicting synthetic rescues in metabolic networks. Mol Syst Biol 4: 168.
6. Fraenkel DG. 1987. Glycolysis, penthose phosphate pathway, and Entner-Doudoroff pathway. In: Neidhardt FC. ed; Escherichia coli and Salmonella typhimurium: Cellular and Molecular Biology. Washington: American Society for Microbiology. p 142-50.
7. Segre D, DeLuna A, Church GM, et al. 2005. Modular epistasis in yeast metabolism. Nat Genet 37: 77-83.
8. Yeh PJ, Hegreness MJ, Aiden AP, et al. 2009. Drug interactions and the evolution of antibiotic resistance. Nat Rev Microbiol 7: 460-6.
9. Kupiec M, Sharan R, Ruppin E. 2007. Genetic interactions in yeast: is robustness going bust? Mol Syst Biol 3: 97.
10. Timmermans J, Van Melderen L. 2009. Conditional essentiality of the csrA gene in Escherichia coli. J Bacteriol 191: 1722-4.
11. Zamboni N, Fendt SM, Ruhl M, et al. 2009. C-13-based metabolic flux analysis. Nat Protoc 4: 878-92.
12. Fong SS, Nanchen A, Palsson BO, et al. 2006. Latent pathway activation and increased pathway capacity enable Escherichia coli adaptation to loss of key metabolic enzymes. J Biol Chem 281: 8024-33.
13. Fong SS, Joyce AR, Palsson BO. 2005. Parallel adaptive evolution cultures of Escherichia coli lead to convergent growth phenotypes with different gene expression states. Genome Res 15: 1365-72.
14. Herring CD, Raghunathan A, Honisch C, et al. 2006. Comparative genome sequencing of Escherichia coli allows observation of bacterial evolution on a laboratory timescale. Nat Genet 38: 1406-12.
15. Shlomi T, Berkman O, Ruppin E. 2005. Regulatory on/off minimization of metabolic flux changes after genetic perturbations. Proc Natl Acad Sci USA 102: 7695-700.
16. Nishikawa T, Gulbahce N, Motter AE. 2008. Spontaneous reaction silencing in metabolic optimization. PLoS Comput Biol 4: e1000236.
17. Burgard AP, Vaidyaraman S, Maranas CD. 2001. Minimal reaction sets for Escherichia coli metabolism under different growth requirements and uptake environments. Biotechnol Prog 17: 791-7.
18. Papp B, Pal C, Hurst LD. 2004. Metabolic network analysis of the causes and evolution of enzyme dispensability in yeast. Nature 429: 661-4.
19. Feist AM, Henry CS, Reed JL, et al. 2007. A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 ORFs and thermodynamic information. Mol Syst Biol 3: 121.
20. Kim D-H, Motter AE. 2009. Slave nodes and the controllability of metabolic networks. New J Phys 11: 113047.
21. Pharkya P, Maranas CD. 2006. An optimization framework for identifying reaction activation/inhibition or elimination candidates for overproduction in microbial systems. Metab Eng 8: 1-13.
22. Isalan M, Lemerle C, Michalodimitrakis K, et al. 2008. Evolvability and hierarchy in rewired bacterial gene networks. Nature 452: 840-45.
23. Cagatay T, Turcotte M, Elowitz MB, et al. 2009. Architecture-dependent noise discriminates functionally analogous differentiation circuits. Cell 139: 512-22.
24. Ma WZ, Trusina A, El-Samad H, et al. 2009. Defining network topologies that can achieve biochemical adaptation. Cell 138: 760-73.
25. Chait R, Craney A, Kishony R. 2007. Antibiotic interactions that select against resistance. Nature 446: 668-71.
26. Blagosklonny MV. 1999. Drug-resistance enables selective killing of resistant leukemia cells: exploiting of drug resistance instead of reversal. Leukemia 13: 2031-5.
27. Hegreness M, Shoresh N, Damian D, et al. 2008. Accelerated evolution of resistance in multidrug environments. Proc Natl Acad Sci USA 105: 13977-81.
28. Bollenbach T, Quan S, Chait R, et al. 2009. Nonoptimal microbial response to antibiotics underlies suppressive drug interactions. Cell 139: 707-18.
29. Dancey JE, Chen HX. 2006. Strategies for optimizing combinations of molecularly targeted anticancer agents. Nat Rev Drug Discov 5: 649-59.
30. Yildirim MA, Goh KI, Cusick ME, et al. 2007. Drug-target network. Nat Biotechnol 25: 1119-26.
31. Keiser MJ, Setola V, Irwin JJ, et al. 2009. Predicting new molecular targets for known drugs. Nature 462: 175-81.
32. Hopkins AL. 2008. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 4: 682-90.
33. Reguly T, Breitkreutz A, Boucher L, et al. 2006. Comprehensive curation and analysis of global interaction networks in Saccharomyces cerevisiae. J Biol 5: 11.
34. Segre D, Vitkup D, Church GM. 2002. Analysis of optimality in natural and perturbed metabolic networks. Proc Natl Acad Sci USA 99: 15112-7.
35. Baba T, Ara T, Hasegawa M, et al. 2006. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol 2: 0008.
36. Gerdes SY, Scholle MD, Campbell JW, et al. 2003. Experimental determination and system level analysis of essential genes in Escherichia coli MG1655. J Bacteriol 185: 5673-84.
37. Hashimoto M, Ichimura T, Mizoguchi H, et al. 2005. Cell size and nucleoid organization of engineered Escherichia coli cells with a reduced genome. Mol Microbiol 55: 137-49.
38. Giaever G, Chu AM, Ni L, et al. 2002. Functional profiling of the Saccharomyces cerevisiae genome. Nature 418: 387-91.
39. Goebl MG, Petes TD. 1986. Most of the yeast genomic sequences are not essential for cell-growth and division. Cell 46: 983-92.
40. Harrison R, Papp B, Pal C, et al. 2007. Plasticity of genetic interactions in metabolic networks of yeast. Proc Natl Acad Sci USA 104: 2307-12.
41. Hillenmeyer ME, Fung E, Wildenhain J, et al. 2008. The chemical genomic portrait of yeast: uncovering a phenotype for all genes. Science 320: 362-5.
42. Wagner A. 2008. Neutralism and selectionism: a network-based reconciliation. Nat Rev Genet 9: 965-74.
43. Fischer E, Sauer U. 2005. Large-scale in vivo flux analysis shows rigidity and suboptimal performance of Bacillus subtilis metabolism. Nat Genet 37: 636-40.
44. Fong SS, Palsson BO. 2004. Metabolic gene-deletion strains of Escherichia coli evolve to computationally predicted growth phenotypes. Nat Genet 36: 1056-8.
45. Burgard AP, Pharkya P, Maranas CD. 2003. OptKnock: a bilevel programming framework for identifying gene knockout strategies for microbial strain optimization. Biotechnol Bioeng 84: 647-57.
46. Fong SS, Burgard AP, Herring CD, et al. 2005. In silico design and adaptive evolution of Escherichia coli for production of lactic acid. Biotechnol Bioeng 91: 643-8.
47. Huttenlocher PR, Dabholkar AS. 1997. Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol 387: 167-78.
48. Bourgeois JP, Rakic P. 1993. Changes of synaptic density in the primary visual-cortex of the macaque monkey from fetal to adult stage. J Neurosci 13: 2801-20.
49. Huttenlocher PR. 1979. Synaptic density in human frontal-cortex-developmental-changes and effects of aging. Brain Res 163: 195-205.
50. Cun YL, Denker JS, Solla SA. 1990. Optimal Brain Damage, Advances in Neural Information Processing Systems. San Francisco: Morgan Kaufmann Publishers, Inc. p 598-605.
51. Hilgetag CC, Theoret H, Pascual-Leone A. 2001. Enhanced visual spatial attention ipsilateral to rTMS-induced 'virtual lesions' of human parietal cortex. Nat Neurosci 4: 953-7.
52. Hilgetag CC, Kotter R, Young MP. 1999. Inter-hemispheric competition of sub-cortical structures is a crucial mechanism in paradoxical lesion effects and spatial neglect. Prog Brain Res 121: 121-41.
53. Lawphongpanich S, Yin Y. 2008. Pareto-improving congestion tolls for road networks. Available at: http://www.ise.ufl.edu/toi/Lawphong-Yin.pdf.
54. Motter AE. 2004. Cascade control and defense in complex networks. Phys Rev Lett 93: 098701.
55. Olson MV. 1999. When less is more: gene loss as an engine of evolutionary change. Am J Hum Genet 64: 18-23.
56. Yngvadottir B, Xue Y, Searle S, et al. 2009. A genome-wide survey of the prevalence and evolutionary forces acting on human nonsense SNPs. Am J Hum Genet 84: 224-34.
57. Palsson BO. 2006. Systems Biology: Properties of Reconstructed Networks. Cambridge, UK: Cambridge University Press.
58. Henry CS, Broadbelt LJ, Hatzimanikatis V. 2007. Thermodynamics-based metabolic flux analysis. Biophys J 92: 1792-1805.
59. Kauffman KJ, Prakash P, Edwards JS. 2003. Advances in flux balance analysis. Curr Opin Biotechnol 14: 491-6.
60. Edwards JS, Palsson BO. 2000. The Escherichia coli MG1655 in silico metabolic genotype: its definition, characteristics, and capabilities. Proc Natl Acad Sci USA 97: 5528-33.